E-LIB Suche - Ergebnisse für: Costa, Daniel B.

1

Targeting of drug-tolerant persister cells as an approach t..:

Izumi, Motohiro ; Costa, Daniel B. ; Kobayashi, Susumu S.
Lung Cancer. , 2024

Link: https://doi.org/10.1016/..

2

A Real-World Study of Patient Characteristics and Clinical ..:

Viray, Hollis ; Piper-Vallillo, Andrew J. ; Widick, Page...
Cancers. 16 (2024) 6 - p. 1079 , 2024

Link: https://doi.org/10.3390/..

3

The Impact of On-Target Resistance Mediated by EGFR-T790M o..:

Kobayashi, Ikei S. ; Shaffer, William ; Viray, Hollis...
JTO Clinical and Research Reports. 5 (2024) 1 - p. 100614 , 2024

Link: https://doi.org/10.1016/..

4

EGFR-directed therapy in lung cancer

Cambridge elements. Elements in molecular oncology

Kim, So Yeon ; Costa, Daniel B. ; Shibahara, Daisuke.. , 2023

Link: https://doi.org/10.1017/..

5

Correction to: EGFR Tyrosine Kinase Inhibitors for the Trea..:

Le, Xiuning ; Nadler, Eric ; Costa, Daniel B..
Targeted Oncology. 19 (2023) 1 - p. 125-125 , 2023

Link: https://doi.org/10.1007/..

6

Disparities in outcomes between Black and White patients in..:

Burns, Laura ; Hsu, Chih-Yuan ; Whisenant, Jennifer G....
Lung Cancer. 186 (2023) - p. 107423 , 2023

Link: https://doi.org/10.1016/..

7

EGFR exon 19 insertion EGFR-K745_E746insIPVAIK and others w..:

Shaffer, William ; Kobayashi, Ikei S. ; Sentana-Lledo, Daniel...
Lung Cancer. 181 (2023) - p. 107250 , 2023

Link: https://doi.org/10.1016/..

8

TIP60 is required for tumorigenesis in non‐small cell lung ..:

Shibahara, Daisuke ; Akanuma, Naoki ; Kobayashi, Ikei S....
Cancer Science. 114 (2023) 6 - p. 2400-2413 , 2023

Link: https://doi.org/10.1111/..

9

Correction to: EGFR Tyrosine Kinase Inhibitors for the Trea..:

Le, Xiuning ; Nadler, Eric ; Costa, Daniel B..
Targeted Oncology. 18 (2023) 6 - p. 991-991 , 2023

Link: https://doi.org/10.1007/..

10

ALK Deletion Exons 2 to 19: Case Report of a Rare ALK Inhib..:

Schoepflin, Zachary R. ; Academia, Emmeline ; Osataphan, Soravis A....
JTO Clinical and Research Reports. 4 (2023) 4 - p. 100489 , 2023

Link: https://doi.org/10.1016/..

11

EGFR Tyrosine Kinase Inhibitors for the Treatment of Metast..:

Le, Xiuning ; Nadler, Eric ; Costa, Daniel B..
Targeted Oncology. 18 (2023) 6 - p. 807-817 , 2023

Link: https://doi.org/10.1007/..

12

Complete pathologic response to short-course neoadjuvant al..:

Sentana-Lledo, Daniel ; Viray, Hollis ; Piper-Vallillo, Andrew J....
Lung Cancer. 172 (2022) - p. 124-126 , 2022

Link: https://doi.org/10.1016/..

13

Preclinical Characterization of Mobocertinib Highlights the..:

Vasconcelos, Pedro E.N.S. ; Kobayashi, Ikei S. ; Kobayashi, Susumu S..
JTO Clinical and Research Reports. 2 (2021) 3 - p. 100105 , 2021

Link: https://doi.org/10.1016/..

14

Association of Extended Dosing Intervals or Delays in Pembr..:

Sehgal, Kartik ; Bulumulle, Anushi ; Brody, Heather...
Clinical Lung Cancer. 22 (2021) 3 - p. e379-e389 , 2021

Link: https://doi.org/10.1016/..

15

Differential Pattern of Resistance and Sensitivity to Diffe..:

Piper-Vallillo, Andrew J. ; Kobayashi, Susumu S. ; Costa, Daniel B.
JTO Clinical and Research Reports. 2 (2021) 3 - p. 100133 , 2021

Link: https://doi.org/10.1016/..